1. Home
  2. CRBU vs LFVN Comparison

CRBU vs LFVN Comparison

Compare CRBU & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • LFVN
  • Stock Information
  • Founded
  • CRBU 2011
  • LFVN N/A
  • Country
  • CRBU United States
  • LFVN United States
  • Employees
  • CRBU N/A
  • LFVN N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRBU Health Care
  • LFVN Health Care
  • Exchange
  • CRBU Nasdaq
  • LFVN Nasdaq
  • Market Cap
  • CRBU 165.8M
  • LFVN 145.2M
  • IPO Year
  • CRBU 2021
  • LFVN N/A
  • Fundamental
  • Price
  • CRBU $1.78
  • LFVN $10.90
  • Analyst Decision
  • CRBU Strong Buy
  • LFVN Strong Buy
  • Analyst Count
  • CRBU 3
  • LFVN 2
  • Target Price
  • CRBU $6.67
  • LFVN $30.50
  • AVG Volume (30 Days)
  • CRBU 729.3K
  • LFVN 165.6K
  • Earning Date
  • CRBU 11-05-2025
  • LFVN 10-28-2025
  • Dividend Yield
  • CRBU N/A
  • LFVN 1.65%
  • EPS Growth
  • CRBU N/A
  • LFVN 226.09
  • EPS
  • CRBU N/A
  • LFVN 0.75
  • Revenue
  • CRBU $9,121,000.00
  • LFVN $228,530,000.00
  • Revenue This Year
  • CRBU $9.23
  • LFVN $8.75
  • Revenue Next Year
  • CRBU N/A
  • LFVN N/A
  • P/E Ratio
  • CRBU N/A
  • LFVN $14.51
  • Revenue Growth
  • CRBU N/A
  • LFVN 14.17
  • 52 Week Low
  • CRBU $0.66
  • LFVN $9.83
  • 52 Week High
  • CRBU $3.00
  • LFVN $27.38
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 46.16
  • LFVN 36.63
  • Support Level
  • CRBU $1.72
  • LFVN $10.39
  • Resistance Level
  • CRBU $1.94
  • LFVN $12.10
  • Average True Range (ATR)
  • CRBU 0.11
  • LFVN 0.86
  • MACD
  • CRBU -0.01
  • LFVN -0.18
  • Stochastic Oscillator
  • CRBU 26.53
  • LFVN 15.08

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: